Chaolin Huang
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Antifungal resistance and susceptibility
- Viral Infections and Vectors
-
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- COVID-19 Clinical Research Studies 11
- SARS-CoV-2 and COVID-19 Research 8
- Tuberculosis Research and Epidemiology 3
- Viral Infections and Vectors 2
- SARS-CoV-2 detection and testing 2
-
- Long-Term Effects of COVID-19 6
- Co-authors
- You Shang (7 shared papers)Xiaojing Zou (3 shared papers)Yu Yuan (2 shared papers)Bin Cao (4 shared papers)Huaqing Shu (2 shared papers)Ying Lin (1 shared paper)Lixue Huang (3 shared papers)Zhibo Liu (3 shared papers)
- Journals
- Frontiers in Medicine (4 papers)Frontiers in Microbiology (2 papers)Signal Transduction and Targeted Therapy (1 paper)Frontiers in Cellular and Infection Microbiology (1 paper)BMC Pulmonary Medicine (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Chaolin Huang
28 papers receiving 369 citations
Peers
Comparison fields: 5 of 90
- Infectious Diseases 192
- Internal Medicine 18
- Neurology 74
- Critical Care and Intensive Care Medicine 11
- Molecular Medicine 6
Countries citing papers authored by Chaolin Huang
This map shows the geographic impact of Chaolin Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaolin Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaolin Huang more than expected).
Fields of papers citing papers by Chaolin Huang
This network shows the impact of papers produced by Chaolin Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaolin Huang. The network helps show where Chaolin Huang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chaolin Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 39 | |
| 2 | 2021 | 34 | |
| 3 | 2020 | 32 | |
| 4 | 2020 | 32 | |
| 5 | 2020 | 26 | |
| 6 | 2021 | 22 | |
| 7 | 2021 | 18 | |
| 8 | 2021 | 16 | |
| 9 | 2022 | 16 | |
| 10 | 2021 | 14 | |
| 11 | 2021 | 14 | |
| 12 | 2020 | 14 | |
| 13 | 2021 | 13 | |
| 14 | 2021 | 10 | |
| 15 | 2020 | 9 | |
| 16 | 2024 | 8 | |
| 17 | 2017 | 8 | |
| 18 | 2020 | 8 | |
| 19 | 2021 | 8 | |
| 20 | 2021 | 7 |
About Chaolin Huang
Chaolin Huang is a scholar working on Infectious Diseases, Neurology, Surgery, Critical Care and Intensive Care Medicine and Ecology, Evolution, Behavior and Systematics, having authored 30 papers that have together received 376 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (11 papers), SARS-CoV-2 and COVID-19 Research (8 papers), Long-Term Effects of COVID-19 (6 papers), Tuberculosis Research and Epidemiology (3 papers), Vector-Borne Animal Diseases (2 papers), Viral Infections and Vectors (2 papers), SARS-CoV-2 detection and testing (2 papers) and COVID-19 and healthcare impacts (2 papers). The work is most often cited by research in Infectious Diseases (192 citations), Internal Medicine (18 citations), Neurology (74 citations), Critical Care and Intensive Care Medicine (11 citations) and Molecular Medicine (6 citations). Chaolin Huang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include You Shang, Xiaojing Zou, Yu Yuan, Bin Cao, Huaqing Shu, Ying Lin, Lixue Huang, Zhibo Liu, Jian Chen and Xiaobo Yang. Their work appears in journals such as Frontiers in Medicine, Frontiers in Microbiology, Signal Transduction and Targeted Therapy, Frontiers in Cellular and Infection Microbiology and BMC Pulmonary Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.